ライフサイエンスコーパス: flow-mediated dilatation

1 elax smooth muscle cells in a process termed flow-mediated dilatation.

2 Endothelial function was assessed by flow-mediated dilatation.

3 renergic blockade resulted in an increase in flow-mediated dilatation.

4 ype mice, CHF markedly impaired NO-dependent flow-mediated dilatation.

5 P=0.27), but did ameliorate the reduction in flow-mediated dilatation (0 hours, 4.0+/-1.0; 2 hours, 3

6 0 days after therapy (absolute difference in flow-mediated dilatation, 0.9%; 95% CI, 0.1 to 1.7; P=0.

7 Flow-mediated dilatation, a marker of endothelial functi

8 ature was investigated using brachial artery flow-mediated dilatation and carotid artery intima-media

9 METHODS AND Brachial artery flow-mediated dilatation and cIMT were measured in 213 n

10 there was no consistent relationship between flow-mediated dilatation and free oxidized homocysteine,

11 stiffness), brachial artery reactivity (both flow-mediated dilatation and sublingual glycerol trinitr

12 diameter of the brachial artery during flow (flow-mediated dilatation), and inflammatory biomarkers a

13 ne artery pulsatility index, brachial artery flow-mediated dilatation, and serum concentrations of pl

14 fy endothelial function (via brachial artery flow-mediated dilatation) at sea level (344 m) and high

15 fy endothelial function (via brachial artery flow-mediated dilatation) at sea level (344 m) and high

16 (by 39.7+/-11.8%; P=0.02) but also inhibited flow-mediated dilatation by approximately 80% (P<0.01).

17 In both loading studies, peak reduction in flow-mediated dilatation coincided with maximal reduced

18 n improved endothelial function (measured as flow-mediated dilatation) compared with placebo (dark ch

19 In regression analysis, improved flow-mediated dilatation correlated closely with the red

20 Peripheral conduit artery flow-mediated dilatation decreases with ageing in humans

21 ved arterial dilatation Deltabrachial artery flow-mediated dilatation/Deltadilation response to glyce

22 Endothelium-dependent flow-mediated dilatation (ED-FMD) of the brachial artery

23 Brachial artery flow-mediated dilatation (endothelium dependent) and nit

24 hours, 31.2+/-3.1 micromol/l, P<0.001), and flow-mediated dilatation fell (0 hours, 4.3+/-0.7; 2 hou

25 Flow-mediated dilatation fell, and concentrations of tot

26 on and structure, we examined conduit artery flow mediated dilatation (FMD), an index of nitric oxide

27 binders and endothelial function measured by flow mediated dilatation (FMD).

28 tion, there was a significant improvement in flow-mediated dilatation (FMD) (endothelial-dependent di

29 al endothelial function as assessed by using flow-mediated dilatation (FMD) and arterial compliance a

30 chial artery diameter, endothelial-dependent flow-mediated dilatation (FMD) and endothelial-independe

31 Flow-mediated dilatation (FMD) and the dilatation after

32 Flow-mediated dilatation (FMD) improved after chronic (1

33 Flow-mediated dilatation (FMD) of conduit arteries is de

34 imary and secondary outcomes were changes in flow-mediated dilatation (FMD) of the brachial artery, a

35 ED was evaluated by means of flow-mediated dilatation (FMD) of the brachial artery.

36 At baseline, brachial artery flow-mediated dilatation (FMD) was 55% lower in older (n

37 Flow-mediated dilatation (FMD) was impaired in the famil

38 thelial function assessed by brachial artery flow-mediated dilatation (FMD) was measured before, imme

39 ma-media thickness (IMT) and brachial artery flow-mediated dilatation (FMD) were measured.

40 a-3) PUFAs on vascular function measured via flow-mediated dilatation (FMD), laser Doppler iontophore

41 Brachial artery flow-mediated dilatation (FMD), normalized for local she

42 Endothelial function, assessed by flow-mediated dilatation (FMD), was measured before, at

43 nction determined with the use of ultrasound flow-mediated dilatation (FMD).

44 ld contribute to post-exercise reductions in flow-mediated dilatation (FMD).

45 P and DBP), central pulse pressure (cPP) and flow-mediated dilatation (FMD).

46 dothelial function in the brachial artery by flow-mediated dilatation (FMD).

47 ctors--ie, lipoproteins, blood pressure, and flow-mediated dilatation (FMD).

48 Endothelium-dependent (hyperemia-induced flow-mediated dilatation [FMD]) and -independent (glycer

49 Eight weeks of heat therapy increased flow-mediated dilatation from 5.6 +/- 0.3 to 10.9 +/- 1.

50 Flow-mediated dilatation improved after treatment with B

51 een changes in HDL-induced NO production and flow-mediated dilatation improvement by ET was evident.

52 ascorbic acid supplementation did not affect flow-mediated dilatation in any group.

53 tors and endothelial function as assessed by flow-mediated dilatation in children and adults.

54 The present article reviews the use of flow-mediated dilatation in clinical cardiovascular rese

55 IR caused a significant reduction in flow-mediated dilatation in control subjects (-5.1%; 95%

56 Impaired flow-mediated dilatation in previously preeclamptic wome

57 Ascorbic acid administration increased flow-mediated dilatation in previously preeclamptic wome

58 hypertensive patients exhibited a decreased flow-mediated dilatation in response to postischemic hyp

59 C), on the human coronary circulation and on flow-mediated dilatation in the forearm.

60 rations > 15-fold in all groups and restored flow-mediated dilatation in the sedentary older men (to

61 l arteries, carotid arteries and aortae, and flow-mediated dilatations in third-order mesenteric resi

62 ontrol subjects during endothelium-dependent flow-mediated dilatation induced by hand skin heating.

63 ement therapy on inflammatory markers and on flow-mediated dilatation is largely beneficial, although

64 s largely beneficial, although the effect on flow-mediated dilatation is modulated according to endot

65 Other outcomes (brachial flow-mediated dilatation, microvascular reactive hyperem

66 At baseline, flow-mediated dilatation (normalized for the hyperaemic

67 However, only flow-mediated dilatation, not risk factors or Framingham

68 Flow-mediated dilatation of the brachial artery increase

69 econdary end points of endothelial function (flow-mediated dilatation of the brachial artery) and car

70 tive than longitudinal imaging for measuring flow-mediated dilatation of the brachial artery.

71 essel endothelial function was assessed with flow-mediated dilatation of the brachial artery.

72 d not significantly affect the percentage of flow-mediated dilatation or other measures of vascular f

73 nship between homocysteine concentration and flow-mediated dilatation (P<0.001).

74 6.0+/-6.4% (n=10; P=0.03) but did not affect flow-mediated dilatation (P=0.55).

75 r n-6 PUFAs did not affect the percentage of flow-mediated dilatation (primary endpoint) or other mea

76 biomarker and vascular function measured as flow-mediated dilatation (R = -0.3, P < 0.01) or endothe

77 tral water immersion, heat therapy increased flow-mediated dilatation, reduced arterial stiffness, re

78 nction was assessed from the brachial artery flow-mediated dilatation response.

79 The primary outcome measure was flow-mediated dilatation; secondary outcome measures inc

80 Flow-mediated dilatation showed a reciprocal relationshi

81 Flow-mediated dilatation testing provides an integrated

82 ere markedly attenuated, and brachial artery flow-mediated dilatation was depressed.

83 Brachial artery flow-mediated dilatation was determined at baseline and

84 Flow-mediated dilatation was determined before IR and af

85 Flow-mediated dilatation was expressed as mean and compa

86 However, flow-mediated dilatation was greater and the plasma leve

87 Flow-mediated dilatation was higher during a pregnancy w

88 Mean (SD) flow-mediated dilatation was lower in women with previou

89 Brachial artery flow-mediated dilatation was measured at baseline and at

90 In patients, flow-mediated dilatation was not affected by fluconazole

91 Similarly, IR-induced reduction in flow-mediated dilatation was not observed in p47-chronic

92 In controls, heating-induced flow-mediated dilatation was reduced by fluconazole, L-N

93 Flow-mediated dilatation was significantly impaired 8 ho

94 Twenty-four hours after treatment, flow-mediated dilatation was significantly lower in the

95 Flow-mediated dilatation was used to assess endothelial

96 dentary human ageing and the preservation of flow-mediated dilatation with physically active ageing.

97 the impairment in peripheral conduit artery flow-mediated dilatation with sedentary human ageing and